Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 23, 1646-1650, November 1, 1963]
© 1963 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chirigos, M. A.
Right arrow Articles by Goldin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chirigos, M. A.
Right arrow Articles by Goldin, A.

Studies with the Murine Leukemogenic Rauscher Virus

II. Chemotherapy of Virus-induced Lymphoid Leukemia

Michael A. Chirigos, Frank J. Rauscher, Ismail A. Kamel*, George R. Fanning and Abraham Goldin

( Biochemical Pharmacology, Laboratory of Viral Oncology, and Pathologic Anatomy Branch, National Cancer Institute, Bethesda, Maryland)

Eight drugs were tested against the Rauscher virus-induced leukemia. In virus-inoculated mice a limited course of drug therapy was initiated after the mice had become leukemic. Netropsin, Melphalan, 6-mercaptopurine, and 5-fluorouracil produced a twofold increase in the survival time of leukemic animals. Cytoxan and Vincristine were moderately effective; p-anisaldehyde thiosemicarbazone and methylglyoxalbis-guanylhydrazone were only minimally effective. Inhibition of splenomegaly was observed in animals subjected to effective therapy.

* Present address, Department of Pathology, Georgetown University Medical School, Washington, D.C.

Received 5/15/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1963 by the American Association for Cancer Research.